As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances in diagnosis and treatment.

A consortium of leading European neurotechnology experts is developing a battery-less implant to treat cancer, severe ...

Longtime Hammonton Gazette Sports Editor Dan Russoman passes away, leaving behind a legacy of passion, community, and ...

A specially engineered antibody capable of delivering RNA therapies to hard-to-reach, treatment-resistant tumors ...

Background: Brain metastases (BM) are common and arise in 30% of lung adenocarcinoma (LUAD) patients. Patients with LUAD that develop BM have significantly poorer outcomes, with a 10-16 month median ...